Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dura substitutes devices market, including market shares of different players within Australia. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Australia Dura Substitutes Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2021, GlobalData’s Market Model methodology determined that the leading player in the dura substitutes market in Australia was B. Braun Melsungen followed by Integra LifeSciences, DePuy Synthes, Collagen Matrix, Medtronic and Baxter International.

Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment. Biological Dura Substitutes are made by bio engineering of tissues from different animals such as cow (bovine pericardium) and pig (porcine intestinal sub mucosal layer). Synthetic Dura Substitutes are made from polymer materials such as Polytetrafluoroethylene (PTFE) and have high tensile strength.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the dura substitutes devices market within Australia was expected to be over $0.8m in 2021.

For the latest complete market share analysis of dura substitutes device market in Australia, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.